THE COMPARATIVE EFFICACY OF TELAPREVIR VERSUS BOCEPREVIR IN TREATMENT-NAIVE AND TREATMENT-EXPERIENCED PATIENTS WITH GENOTYPE 1 CHRONIC HEPATITIS

被引：2
|
作者：
Diels, J. [1 ]
Cure, S. [2 ]
Gavart, S. [3 ]
机构：
[1] Janssen Pharmaceut NV, Janssen EMEA Hlth Econ & Market Access, Beerse, Belgium
[2] I3 Innovus, Uxbridge, Middx, England
[3] Janssen Pharmaceut NV, Worldwide Market Access, Janssen Global Serv, Beerse, Belgium
来源：
VALUE IN HEALTH | 2011年 / 14卷 / 07期
关键词：
D O I：
10.1016/j.jval.2011.08.195
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A266 / A266
页数：1
相关论文
共 50 条
  • [1] Efficacy of telaprevir and boceprevir in treatment-naive and treatment-experienced genotype 1 chronic hepatitis C patients: an indirect comparison using Bayesian network meta-analysis
    Cure, S.
    Diels, J.
    Gavart, S.
    Bianic, F.
    Jones, E.
    CURRENT MEDICAL RESEARCH AND OPINION, 2012, 28 (11) : 1841 - 1856
  • [2] Effectiveness of Telaprevir or Boceprevir in Treatment-Experienced Patients With HCV Genotype 1 Infection and Cirrhosis
    Hezode, Christophe
    Fontaine, Helene
    Dorival, Celine
    Zoulim, Fabien
    Larrey, Dominique
    Canva, Valerie
    De Ledinghen, Victor
    Poynard, Thierry
    Samuel, Didier
    Bourliere, Marc
    Alric, Laurent
    Raabe, Jean-Jacques
    Zarski, Jean-Pierre
    Marcellin, Patrick
    Riachi, Ghassan
    Bernard, Pierre-Henri
    Loustaud-Ratti, Veronique
    Chazouilleres, Olivier
    Abergel, Armand
    Guyader, Dominique
    Metivier, Sophie
    Tran, Albert
    Di Martino, Vincent
    Causse, Xavier
    Dao, Thong
    Lucidarme, Damien
    Portal, Isabelle
    Cacoub, Patrice
    Gournay, Jerome
    Grando-Lemaire, Veronique
    Hillon, Patrick
    Attali, Pierre
    Fontanges, Thierry
    Rosa, Isabelle
    Petrov-Sanchez, Ventzislava
    Barthe, Yoann
    Pawlotsky, Jean-Michel
    Pol, Stanislas
    Carrat, Fabrice
    Bronowicki, Jean-Pierre
    GASTROENTEROLOGY, 2014, 147 (01) : 132 - U235
  • [3] Hepatitis C Viral Evolution in Genotype 1 Treatment-Naive and Treatment-Experienced Patients Receiving Telaprevir-Based Therapy in Clinical Trials
    Kieffer, Tara L.
    De Meyer, Sandra
    Bartels, Doug J.
    Sullivan, James C.
    Zhang, Eileen Z.
    Tigges, Ann
    Dierynck, Inge
    Spanks, Joan
    Dorrian, Jennifer
    Jiang, Min
    Adiwijaya, Bambang
    Ghys, Anne
    Beumont, Maria
    Kauffman, Robert S.
    Adda, Nathalie
    Jacobson, Ira M.
    Sherman, Kenneth E.
    Zeuzem, Stefan
    Kwong, Ann D.
    Picchio, Gaston
    PLOS ONE, 2012, 7 (04):
  • [4] ADDITIONAL BOCEPREVIR INCREASES SUSTAINED VIROLOGICAL RESPONSE (SVR) RATES IN TREATMENT-NAIVE AND TREATMENT-EXPERIENCED CHRONIC HEPATITIS C VIRUS (HCV) GENOTYPE 1 INFECTION
    Desai, Mitesh
    SEXUALLY TRANSMITTED INFECTIONS, 2011, 87 (05) : 449 - 449
  • [5] Efficacy and safety of sofosbuvir-based therapy for the treatment of chronic hepatitis C in treatment-naive and treatment-experienced patients
    Liu, Xi
    Wang, Yawen
    Zhang, Guanjun
    Li, Na
    Zhu, Qianqian
    Chang, Hongyun
    Han, Qunying
    Lv, Yi
    Liu, Zhengwen
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2014, 44 (02) : 145 - 151
  • [6] The Relative Efficacy of Boceprevir and Telaprevir in the Treatment of Hepatitis C Virus Genotype 1
    Kieran, Jennifer
    Schmitz, Susanne
    O'Leary, Aisling
    Walsh, Cathal
    Bergin, Colm
    Norris, Suzanne
    Barry, Michael
    CLINICAL INFECTIOUS DISEASES, 2013, 56 (02) : 228 - 235
  • [7] COST PER CURE OF TELAPREVIR AND BOCEPREVIR IN TREATMENT-NAIVE GENOTYPE 1 HEPATITIS C PATIENTS WITH F2 FIBROSIS IN BRAZIL
    Morais, A. D.
    Pereira, M. L.
    VALUE IN HEALTH, 2013, 16 (07) : A352 - A352
  • [8] COST-EFFECTIVENESS OF TRIPLE THERAPY WITH TELAPREVIR FOR THE TREATMENT OF TREATMENT-NAIVE GENOTYPE 1 CHRONIC HEPATITIS C PATIENTS IN GERMANY
    Stahmeyer, J. T.
    Schauer, S.
    Wirth, D.
    Fleischmann, J.
    Lee, S.
    Gavart, S.
    Bianic, F.
    Cure, S.
    Krauth, C.
    VALUE IN HEALTH, 2012, 15 (07) : A396 - A396
  • [9] Work productivity among treatment-naive patients with genotype 1 chronic hepatitis C infection receiving telaprevir combination treatment
    Aggarwal, J.
    Vera-Llonch, M.
    Donepudi, M.
    Suthoff, E.
    Younossi, Z.
    Goss, T. F.
    JOURNAL OF VIRAL HEPATITIS, 2015, 22 (01) : 8 - 17
  • [10] C-SURFER: GRAZOPREVIR PLUS ELBASVIR IN TREATMENT-NAIVE AND TREATMENT-EXPERIENCED PATIENTS WITH HEPATITIS C VIRUS GENOTYPE 1 INFECTION AND CHRONIC KIDNEY DISEASE
    Roth, D.
    Nelson, D.
    Bruchfeld, A.
    Liapakis, A.
    Silva, M.
    Monsour, H., Jr.
    Martin, P.
    Pol, S.
    Londono, M. -C.
    Hassanein, T.
    Zamor, P.
    Zuckerman, E.
    Zhao, Y.
    Wan, S.
    Jackson, B.
    Robertson, M.
    Wahl, J.
    Barr, E.
    Greaves, W.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S263 - S264
12345